ArticleJournal of gastrointestinal oncology2022

Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients.

Jixue Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.